Nationwide Fund Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-716
| Closed | -$453K | – | 3302 |
|
|
2015
Q2 | $453K | Buy |
716
+535
| +296% | +$338K | ﹤0.01% | 2298 |
|
|
2015
Q1 | $93K | Sell |
181
-310
| -63% | -$159K | ﹤0.01% | 2980 |
|
|
2014
Q4 | $263K | Buy |
491
+36
| +8% | +$19.3K | ﹤0.01% | 2505 |
|
|
2014
Q3 | $682K | Buy |
455
+275
| +153% | +$412K | ﹤0.01% | 2035 |
|
|
2014
Q2 | $247K | Buy |
180
+54
| +43% | +$74.1K | ﹤0.01% | 2643 |
|
|
2014
Q1 | $175K | Buy |
126
+7
| +6% | +$9.72K | ﹤0.01% | 2542 |
|
|
2013
Q4 | $118K | Sell |
119
-3
| -2% | -$2.98K | ﹤0.01% | 2904 |
|
|
2013
Q3 | $127K | Buy |
122
+11
| +10% | +$11.5K | ﹤0.01% | 2870 |
|
|
2013
Q2 | $122K | Buy |
+111
| New | +$122K | ﹤0.01% | 2720 |
|